Trial · NCT05885737
Results by group90
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 90
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline in the Weekly Mean of the Daily 24-hour WI-NRS Score at Week 4 of the DB Period | DB Period: Difelikefalin | -2.09 | Standard Error 0.198 | score on a scale | |
| Change From Baseline in the Weekly Mean of the Daily 24-hour WI-NRS Score at Week 4 of the DB Period | DB Period: Placebo | -1.27 | Standard Error 0.194 | score on a scale | |
| Percentage of Participants Achieving Greater Than or Equal to (>=) 3-point Improvement From Baseline With Respect to the Weekly Mean of the Daily 24-hour WI-NRS in the DB Period | DB Period: Difelikefalin | Week 4 | 21.9 | 95% Confidence Interval 11.4 to 38.1 | percentage of participants |
| Percentage of Participants Achieving Greater Than or Equal to (>=) 3-point Improvement From Baseline With Respect to the Weekly Mean of the Daily 24-hour WI-NRS in the DB Period | DB Period: Placebo | Week 4 | 8.9 | 95% Confidence Interval 3.9 to 19.0 | percentage of participants |
| Percentage of Participants Achieving Greater Than or Equal to (>=) 3-point Improvement From Baseline With Respect to the Weekly Mean of the Daily 24-hour WI-NRS in the DB Period | DB Period: Difelikefalin | Week 8 | 35.8 | 95% Confidence Interval 22.7 to 51.3 | percentage of participants |
| Percentage of Participants Achieving Greater Than or Equal to (>=) 3-point Improvement From Baseline With Respect to the Weekly Mean of the Daily 24-hour WI-NRS in the DB Period | DB Period: Placebo | Week 8 | 22.3 | 95% Confidence Interval 12.9 to 35.8 | percentage of participants |
| Percentage of Participants Achieving Greater Than or Equal to (>=) 3-point Improvement From Baseline With Respect to the Weekly Mean of the Daily 24-hour WI-NRS in the DB Period | DB Period: Difelikefalin | Week 12 | 48.7 | 95% Confidence Interval 34.2 to 63.3 | percentage of participants |
| Percentage of Participants Achieving Greater Than or Equal to (>=) 3-point Improvement From Baseline With Respect to the Weekly Mean of the Daily 24-hour WI-NRS in the DB Period | DB Period: Placebo | Week 12 | 33.8 | 95% Confidence Interval 22.0 to 48.0 | percentage of participants |
| Percentage of Participants Achieving at Least 4-point Improvement From Baseline With Respect to the Weekly Mean of the Daily 24-hour WI-NRS in the DB Period | DB Period: Difelikefalin | Week 4 | 10.9 | 95% Confidence Interval 3.7 to 28.1 | percentage of participants |
| Percentage of Participants Achieving at Least 4-point Improvement From Baseline With Respect to the Weekly Mean of the Daily 24-hour WI-NRS in the DB Period | DB Period: Placebo | Week 4 | 2.2 | 95% Confidence Interval 0.5 to 8.8 | percentage of participants |
| Percentage of Participants Achieving at Least 4-point Improvement From Baseline With Respect to the Weekly Mean of the Daily 24-hour WI-NRS in the DB Period | DB Period: Difelikefalin | Week 8 | 21.2 | 95% Confidence Interval 11.2 to 36.6 | percentage of participants |
| Percentage of Participants Achieving at Least 4-point Improvement From Baseline With Respect to the Weekly Mean of the Daily 24-hour WI-NRS in the DB Period | DB Period: Placebo | Week 8 | 11.6 | 95% Confidence Interval 5.4 to 23.2 | percentage of participants |
| Percentage of Participants Achieving at Least 4-point Improvement From Baseline With Respect to the Weekly Mean of the Daily 24-hour WI-NRS in the DB Period | DB Period: Difelikefalin | Week 12 | 29.9 | 95% Confidence Interval 18.1 to 45.3 | percentage of participants |
| Percentage of Participants Achieving at Least 4-point Improvement From Baseline With Respect to the Weekly Mean of the Daily 24-hour WI-NRS in the DB Period | DB Period: Placebo | Week 12 | 19.7 | 95% Confidence Interval 10.9 to 32.9 | percentage of participants |
| Change From Baseline in the Weekly Mean of the 24-hour WI-NRS Score at Each Week of the DB Period | DB Period: Difelikefalin | Week 1 | -0.68 | Standard Error 0.153 | score on a scale |
| Change From Baseline in the Weekly Mean of the 24-hour WI-NRS Score at Each Week of the DB Period | DB Period: Placebo | Week 1 | -0.53 | Standard Error 0.149 | score on a scale |
| Change From Baseline in the Weekly Mean of the 24-hour WI-NRS Score at Each Week of the DB Period | DB Period: Difelikefalin | Week 2 | -1.37 | Standard Error 0.179 | score on a scale |
| Change From Baseline in the Weekly Mean of the 24-hour WI-NRS Score at Each Week of the DB Period | DB Period: Placebo | Week 2 | -0.89 | Standard Error 0.175 | score on a scale |
| Change From Baseline in the Weekly Mean of the 24-hour WI-NRS Score at Each Week of the DB Period | DB Period: Difelikefalin | Week 3 | -1.86 | Standard Error 0.188 | score on a scale |
| Change From Baseline in the Weekly Mean of the 24-hour WI-NRS Score at Each Week of the DB Period | DB Period: Placebo | Week 3 | -1.08 | Standard Error 0.185 | score on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05885737/results